James Q. Del Rosso

James Q. Del Rosso's AcademicInfluence.com Rankings

James Q. Del Rosso

Philosophy

#7582

World Rank

#10817

Historical Rank

Logic

#4633

World Rank

#5950

Historical Rank

philosophy Degrees

Download Badge

Philosophy

James Q. Del Rosso's Degrees

PhD Biomedical Sciences Stanford University

Why Is James Q. Del Rosso Influential?

(Suggest an Edit or Addition)

(See a Problem?)

James Q. Del Rosso's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. (2007) (193)
Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne (2013) (191)
Corticosteroids: options in the era of steroid-sparing therapy. (2005) (141)
Current modalities and new advances in the treatment of basal cell carcinoma (2006) (135)
The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. (2011) (121)
Anti-inflammatory activity of tetracyclines. (2007) (103)
Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. (2012) (102)
Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea. (2008) (93)
Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. (2013) (93)
Prevalence of superficial fungal infections among sports‐active individuals: results from the Achilles survey, a review of the literature (2001) (85)
Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations (2017) (83)
Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel† (2019) (79)
Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. (2007) (76)
Onychomycosis in children: prevalence and management. (1998) (75)
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care. (2013) (73)
Pathogenesis of acne vulgaris: recent advances. (2009) (70)
Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review (2017) (70)
Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience. (2012) (69)
Anti-TNF agents for the treatment of psoriasis. (2009) (66)
Atypical mycobacterial cutaneous infections. (2009) (64)
The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. (2014) (64)
Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. (2010) (62)
Adult seborrheic dermatitis: a status report on practical topical management. (2011) (60)
Optimizing use of oral antibiotics in acne vulgaris. (2009) (59)
Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. (2019) (59)
Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices. (2014) (58)
Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations (2011) (56)
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents. (2013) (56)
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. (2014) (55)
Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. (2011) (55)
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies. (2014) (55)
The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. (2014) (55)
Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea. (2012) (54)
Evidence‐based recommendations for the management of acne fulminans and its variants (2017) (52)
Use of oral isotretinoin in the management of rosacea. (2011) (52)
Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? (2013) (50)
Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications. (2016) (50)
Acne severity grading: determining essential clinical components and features using a Delphi consensus. (2012) (49)
Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. (2008) (48)
A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. (2009) (48)
Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy? (2013) (48)
A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. (2010) (47)
Management of facial erythema of rosacea: What is the role of topical α-adrenergic receptor agonist therapy? (2013) (47)
Dermatofibrosarcoma protuberans: a case report and review of the literature. (2008) (45)
Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. (2013) (44)
Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin. (2013) (44)
Skin cancer in asians: part 1: nonmelanoma skin cancer. (2009) (43)
Status report on antibiotic resistance: implications for the dermatologist. (2007) (43)
Evolving perspectives on the etiology and pathogenesis of acne vulgaris. (2015) (43)
Update on rosacea pathogenesis and correlation with medical therapeutic agents. (2006) (43)
An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents (2000) (42)
Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, (2016) (42)
Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton. (2009) (42)
American Acne & Rosacea Society rosacea medical management guidelines. (2008) (41)
The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. (2007) (41)
Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation. (2015) (41)
Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. (2008) (40)
An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea. (2013) (40)
Skin cancer in asians: part 2: melanoma. (2009) (40)
Itch: an under‐recognized problem in psoriasis (2019) (39)
Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant. (2011) (39)
Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. (2009) (39)
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. (2010) (38)
Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS). (2019) (38)
Hepatic Safety of Itraconazole (2002) (37)
Understanding the Epidermal Barrier in Healthy and Compromised Skin: Clinically Relevant Information for the Dermatology Practitioner: Proceedings of an Expert Panel Roundtable Meeting. (2016) (37)
Severe neutropenia associated with oral terbinafine therapy. (1998) (37)
A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines. (2004) (36)
Medical treatment of rosacea with emphasis on topical therapies (2004) (36)
Advances in Understanding and Managing Rosacea: Part 2: The Central Role, Evaluation, and Medical Management of Diffuse and Persistent Facial Erythema of Rosacea (2012) (36)
Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit. (2014) (36)
A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance. (2007) (35)
Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea. (2010) (34)
Examining the importance of laboratory and diagnostic testing when treating and diagnosing onychomycosis (2018) (33)
Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin. (2012) (33)
Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. (2007) (32)
Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. (2011) (31)
Betamethasone Valerate in Foam Vehicle Is Effective with Both Daily and Twice a Day Dosing: A Single-Blind, Open-Label Study in the Treatment of Scalp Psoriasis (2001) (31)
Medical treatment of rosacea with emphasis on topical therapies. (2004) (31)
Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. (2000) (31)
Comprehensive medical management of rosacea: an interim study report and literature review. (2008) (30)
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. (2020) (30)
The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection. (2013) (30)
Status Report on Topical Hypochlorous Acid: Clinical Relevance of Specific Formulations, Potential Modes of Action, and Study Outcomes. (2018) (30)
Pathways to managing atopic dermatitis: consensus from the experts. (2013) (29)
A status report on drug-associated acne and acneiform eruptions. (2010) (29)
Topical antibiotics: therapeutic value or ecologic mischief? (2009) (28)
The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician? (2013) (27)
From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology. (2014) (27)
Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis. (2011) (26)
Shortcomings in rosacea diagnosis and classification (2017) (26)
Recently approved systemic therapies for acne vulgaris and rosacea. (2007) (26)
Tinea capitis in infants: recognition, evaluation, and management suggestions. (2012) (26)
Healthcare utilization and costs of patients with rosacea in an insured population. (2008) (26)
Applying the phenotype approach for rosacea to practice and research (2018) (25)
Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne. (2008) (25)
Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. (2007) (25)
Face to face with oral isotretinoin: a closer look at the spectrum of therapeutic outcomes and why some patients need repeated courses. (2012) (25)
Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. (2012) (24)
Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris. (2007) (24)
Wound care in the dermatology office: where are we in 2011? (2011) (23)
Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin. (2013) (23)
Systemic therapy for rosacea: focus on oral antibiotic therapy and safety (2000) (23)
Optimizing topical therapies for treating psoriasis: a consensus conference. (2010) (22)
Update on rosacea pathogenesis and correlation with medical therapeutic agents. (2006) (22)
Adult seborrheic dermatitis: a status report on practical topical management. (2011) (22)
The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. (2014) (21)
Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now? (2017) (21)
The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. (2009) (21)
Topical corticosteroid application and the structural and functional integrity of the epidermal barrier. (2013) (21)
Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology (2019) (21)
Optimal management of papulopustular rosacea: rationale for combination therapy. (2012) (21)
Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis. (1997) (21)
Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris. (2015) (20)
A Closer Look at Seborrheic Keratoses: Patient Perspectives, Clinical Relevance, Medical Necessity, and Implications for Management. (2017) (20)
Overcoming the Barrier Treatment of Ichthyosis: A Combination-therapy Approach. (2010) (19)
Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management. (2013) (19)
Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy. (2007) (19)
Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations. (2004) (19)
The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. (2009) (19)
Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. (2005) (18)
The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey. (2017) (18)
Clinical relevance of maintaining the structural and functional integrity of the stratum corneum: why is it important to you? (2011) (18)
Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach. (2011) (18)
Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel. (2018) (18)
The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach. (2012) (17)
The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel. (2009) (17)
Minocycline 1.5% Foam for the Topical Treatment of Moderate-to-Severe Papulopustular Rosacea: Results of Two Phase 3, Randomized, Clinical Trials. (2020) (17)
The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. (2009) (17)
A status report on the medical management of rosacea: focus on topical therapies. (2002) (17)
Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence. (2008) (17)
Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam. (2017) (17)
Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach. (2014) (16)
Oral antibiotic drug interactions of clinical significance to dermatologists. (2009) (16)
A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. (2013) (16)
Antifungal agents for onychomycosis: new treatment strategies to improve safety. (2016) (16)
Efinaconazole 10% solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential. (2013) (15)
Management of cutaneous rosacea: emphasis on new medical therapies (2014) (15)
Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation. (2015) (15)
Clinical significance of brand versus generic formulations: focus on oral minocycline. (2006) (15)
Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. (2011) (15)
Verruciform xanthoma of the glans penis: a benign clinical simulant of genital malignancy. (1993) (15)
The use of topical imiquimod for the treatment of actinic keratosis: a status report. (2005) (15)
The use of the new oral antifungal agents, itraconazole, terbinafine, and fluconazole to treat onychomycosis and other dermatomycoses (2001) (15)
Combination topical therapy in the treatment of acne. (2006) (14)
Azelaic acid gel 15%: clinical versatility in the treatment of rosacea. (2006) (14)
Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability. (2008) (14)
Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea. (2017) (14)
Current management of onychomycosis and dermatomycoses (2000) (14)
Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. (2005) (14)
Acute generalized exanthematous pustulosis: an enigmatic drug-induced reaction. (2009) (14)
BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris. (2018) (14)
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials. (2022) (13)
Atopic dermatitis and the stratum corneum: part 3: the immune system in atopic dermatitis. (2013) (13)
Efficacy, safety, and subject satisfaction of a specified skin care regimen to cleanse, medicate, moisturize, and protect the skin of patients under treatment for acne vulgaris. (2015) (13)
Effectiveness and safety of modified-release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community-based trial in subgroups based on gender. (2012) (12)
Topical Corticosteroid Therapy for Psoriasis-A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification. (2020) (12)
Oral Apremilast for the Treatment of Plaque Psoriasis. (2016) (12)
Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. (2013) (12)
Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections (1998) (12)
The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris. (2017) (12)
The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection. (2013) (12)
Multivesicular Emulsion Ceramide-containing Moisturizers: An Evaluation of Their Role in the Management of Common Skin Disorders. (2016) (12)
Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin. (2011) (12)
Anti-inflamatory dose doxycycline in the treatment of rosacea. (2009) (12)
New and emerging topical approaches for actinic keratoses. (2003) (12)
MONOCLONAL ANTIBODY THERAPIES for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management? (2019) (12)
New and emerging topical approaches for actinic keratoses. (2003) (12)
A novel hydrogel vehicle formulated for the treatment of atopic dermatitis. (2007) (11)
The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. (2006) (11)
Application of protease technology in dermatology: rationale for incorporation into skin care with initial observations on formulations designed for skin cleansing, maintenance of hydration, and restoration of the epidermal permeability barrier. (2013) (11)
Topical and oral antibiotics for acne vulgaris. (2016) (11)
Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid. (2014) (11)
Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair. (2014) (11)
Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. (2013) (11)
Recently approved systemic therapies for acne vulgaris and rosacea. (2007) (11)
Spotlight on the Use of Nitric Oxide in Dermatology: What Is It? What Does It Do? Can It Become an Important Addition to the Therapeutic Armamentarium for Skin Disease? (2017) (11)
The use of intermittent itraconazole therapy for superficial mycotic infections: a review and update on the 'one week' approach. (1999) (11)
Management of truncal acne vulgaris: current perspectives on treatment. (2006) (11)
Primary carcinosarcoma of the ear: case report and review of the literature. (2009) (10)
Calciphylaxis: a review. (2008) (10)
Classification, pathophysiology, and treatment of rosacea (2004) (10)
Newer topical therapies for the treatment of acne vulgaris. (2007) (10)
Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis. (2009) (10)
What is the Role of Benzoyl Peroxide Cleansers in Acne Management?: Do they Decrease Propionibacterium acnes Counts? Do they Reduce Acne Lesions? (2008) (10)
The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. (2009) (10)
Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluation. (2015) (10)
Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference. (2011) (10)
Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model. (2009) (10)
The Clinical Relevance of Antibiotic Resistance: Thirteen Principles That Every Dermatologist Needs to Consider When Prescribing Antibiotic Therapy. (2016) (10)
Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses. (2009) (10)
Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: topical therapies. (2015) (9)
When Acne is Not Acne. (2016) (9)
Tretinoin photostability: comparison of micronized tretinoin gel 0.05% and tretinoin gel 0.025% following exposure to fluorescent and solar light. (2013) (9)
Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study (2019) (9)
The role of the vehicle in combination acne therapy. (2005) (9)
Polypodium leucotomos extract: a status report on clinical efficacy and safety. (2015) (9)
Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis. (2013) (9)
Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes. (2016) (9)
Erythropoietic protoporphyria: a case report and literature review. (2010) (9)
Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis (1997) (9)
Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data. (2008) (9)
Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials. (2021) (9)
Truncal Acne: A Neglected Entity (2019) (9)
Current approach to acne management: a community-based analysis. (2009) (9)
Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial. (2010) (8)
Skin manifestations of drug reactions (2002) (8)
Ingenol Mebutate Topical Gel A Status Report On Clinical Use Beyond Actinic Keratosis. (2016) (8)
The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" excipients. (2013) (8)
An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period. (2019) (8)
Oral Antibiotic Drug Interactions of Clinical Significance to Dermatologists (2009) (8)
Sarecycline: A Review of Preclinical and Clinical Evidence (2020) (8)
Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%). (2010) (8)
Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data. (2008) (8)
Androgens, Androgen Receptors, and the Skin: From the Laboratory to the Clinic With Emphasis on Clinical and Therapeutic Implications. (2020) (8)
Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity. (2018) (8)
Trolamine-containing topical emulsion: clinical applications in dermatology. (2008) (8)
Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized Patients. (2018) (8)
Patient Awareness of Antimicrobial Resistance and Antibiotic Use in Acne Vulgaris. (2019) (8)
Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin. (2011) (7)
Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris. (2020) (7)
Comprehensive management of patients with superficial fungal infections: the role of sertaconazole nitrate. (2008) (7)
Topical Cantharidin in the Management of Molluscum Contagiosum: Preliminary Assessment of an Ether-free, Pharmaceutical-grade Formulation. (2019) (7)
Comparative efficacy and safety results of topical hemostatic powder and sterile compressed foam sponge in second intention healing following Mohs micrographic surgery. (2010) (7)
A status report on topical tazarotene in the management of acne vulgaris. (2013) (7)
Wound care in the dermatology office: Where are we in 2011? (2011) (7)
Management of cutaneous rosacea: emphasis on new medical therapies (2014) (7)
Rethinking the Journal Impact Factor and Publishing in the Digital Age. (2020) (7)
Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: oral therapies. (2015) (7)
Betamethasone Valerate in Foam Vehicle is Effective with Both Daily and Twice a Day Dosing: A Single-Blind, Open-Label Study in the Treatment of Scalp Psoriasis (2001) (7)
Laser and light-based therapies for acne vulgaris: a current guide based on available data. (2010) (7)
Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota (2022) (7)
The Effect of Calcipotriene-Betamethasone Dipropionate Aerosol Foam versus Vehicle on Target Lesions in Moderate Severity Plaque Psoriasis: Focus on Elbows and Knees (2019) (6)
Tretinoin photostability: comparison of micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to ultraviolet a light. (2012) (6)
Modern methods to treat superficial fungal disease. (2007) (6)
Use of Polypodium leucotomas Extract in Clinical Practice: A Primer for the Clinician. (2016) (6)
Topical and oral antibiotics for acne vulgaris. (2016) (6)
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options. (2006) (6)
An update on newer topical therapies for actinic keratoses: advances and applications. (2003) (6)
Activity of Dapsone versus Community and Hospital Pathogens from the CANWARD Study. (2016) (6)
Update from the Scientific Panel on Antibiotic Use in Dermatology: clinical considerations for the dermatologist. (2008) (6)
Avoiding the legal "blemish": medicolegal pitfalls in dermatology. (2009) (6)
The Use of Oral Antibiotics in the Management of Rosacea (2019) (5)
Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy. (2007) (5)
Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam. (2017) (5)
Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials (2021) (5)
Oral cephalosporin antibiotics: an overview of clinical pharmacology and dermatologic applications. (2003) (5)
The treatment of viral infections and nonmelanoma skin cancers. (2007) (5)
The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid. (2006) (5)
Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential. (2019) (5)
Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices. (2021) (5)
A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses. (2012) (5)
Biologic Therapies in the Treatment of Hidradenitis Suppurativa (2010) (5)
An Aluminum Magnesium Hydroxide Stearate-based Skin Barrier Protection Cream Used for the Management of Eczematous Dermatitis: A Summary of Completed Studies. (2008) (4)
The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. (2006) (4)
A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. (2009) (4)
Mycetoma clinically masquerading as squamous cell carcinoma: case report and literature review. (2009) (4)
Comprehensive management of patients with superficial fungal infections: the role of sertaconazole nitrate. (2008) (4)
Topical therapy for acne in women: is there a role for clindamycin phosphate-benzoyl peroxide gel? (2014) (4)
An update on newer topical therapies for actinic keratoses: advances and applications. (2003) (4)
Revisiting the Beneficial Effects of Estrogen on the Skin: A Comprehensive Review of the Literature and a Look to the Future (2018) (4)
Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panel (2021) (4)
Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair. (2014) (4)
Use of Topical Tazarotene for the Treatment of Acne Vulgaris in Pregnancy: A Literature Review. (2020) (4)
Lidose-Isotretinoin Administered Without Food Improves Quality of Life in Patients With Severe Recalcitrant Nodular Acne: An Open-Label, Single-Arm, Phase IV Study. (2020) (4)
Retinoic acid receptors and topical acne therapy: establishing the link between gene expression and drug efficacy. (2002) (4)
Skin manifestations of drug reactions. (2002) (4)
Not all topical corticosteroids are created equal! Optimizing therapeutic outcomes through better understanding of vehicle formulations, compound selection,and methods of application. (2012) (4)
Oral Antibiotics in Dermatology: A Practical Overview with Clinically Relevant Correlations and Management Suggestions (2018) (4)
The Role of Skin Care and Maintaining Proper Barrier Function in the Management of Rosacea (2010) (4)
A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of acne vulgaris: aesthetic characteristics, patient preference considerations, and impact on compliance with treatment. (2009) (4)
Topical imiquimod therapy for actinic keratosis: is long-term clearance a realistic benefit? (2008) (4)
Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis. (2018) (4)
Clinical efficacy & safety of oral Polypodium leucotomos extract for photoprotection: A systematic review (2018) (4)
Selection of therapy for acne vulgaris: balancing concerns about antibiotic resistance. (2008) (4)
Acne and the Internet. (2016) (4)
Perspectives on seborrheic dermatitis: looking back to move ahead. (2009) (4)
Perspectives on seborrheic dermatitis: looking back to move ahead (2009) (4)
Defining criteria used to evaluate response to treatment of acne vulgaris. (2006) (3)
Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes. (2016) (3)
Weight-based Dosing and Extended-release Formulation of Minocycline Tablets: Is There Clinical Significance? (2009) (3)
What's New in the Medicine Cabinet?: A Panoramic Review of Clinically Relevant Information for the Busy Dermatologist. (2014) (3)
Management of tinea capitis. A status report. (1999) (3)
Medical treatment of rosacea with emphasis on topical therapies (2004) (3)
Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex. (2021) (3)
Factors influencing optimal skin care and product selection (2005) (3)
The use of topical azelaic acid 15% gel or metronidazole 0.75% gel for the treatment of rosacea: evaluation of a single-site comparative trial subset 1 (2004) (3)
Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea. (2020) (3)
Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin. (2018) (3)
Topical Oxymetazoline Hydrochloride Cream 1% for the Treatment of Persistent Facial Erythema of Rosacea in Adults: A Comprehensive Review of Current Evidence. (2021) (3)
Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits (2021) (3)
Topical metronidazole combination therapy in the clinical management of rosacea. (2005) (3)
Sarecycline treatment for acne vulgaris: Rationale for weight‐based dosing and limited impact of food intake on clinical efficacy (2021) (3)
Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel for the Treatment of Acne Vulgaris: Which Patients are Most Likely to Benefit the Most? (2015) (3)
SARECYCLINE AND THE NARROW-SPECTRUM TETRACYCLINE CONCEPT: Currently Available Data and Potential Clinical Relevance in Dermatology. (2020) (3)
Application of Nail Polish During Topical Management of Onychomycosis: Are Data Available to Guide the Clinician About What to Tell Their Patients? (2016) (3)
Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05. (2017) (3)
Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts panel (2021) (3)
Use of Polypodium leucotomas Extract in Clinical Practice: A Primer for the Clinician. (2016) (3)
Capsule Commentaries: Drug Reaction Considerations with Oral Minocycline (2018) (3)
Treatment of Darier's disease with isotretinoin: report of a case. (1986) (3)
Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application. (2014) (3)
Oral cephalosporin antibiotics: an overview of clinical pharmacology and dermatologic applications. (2003) (3)
Tackling the anterior nares and other sites of colonization: implications for the dermatologist. (2007) (3)
Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications. (2010) (3)
The ORCA (Oracea for rosacea: a community-based assessment) trial: a large-scale, phase 4 trial in papulopustular rosacea. (2010) (3)
Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy (1996) (3)
Topical Treatment of Skin Cancer (2011) (3)
Antibiotic resistance: overview and significance in dermatology. (2005) (2)
Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily (2021) (2)
The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream. (2012) (2)
TREATMENT OF ONYCHOMYCOSIS AND TINEA PEDIS WITH INTERMITTENT ITRACONAZOLE THERAPY (1996) (2)
Cephalosporins in dermatology. (2003) (2)
Topical tazarotene in acne vulgaris: treatment approaches. (2004) (2)
The Personalised Acne Care Pathway—Recommendations to guide longitudinal management from the Personalising Acne: Consensus of Experts (2021) (2)
Therapeutic experience with cefdinir in the treatment of uSSSIs (2006) (2)
Future trends in the treatment of rosacea (2005) (2)
When do efficacy outcomes in clinical trials correlate with clinical relevance? analysis of clindamycin phosphate 1.2%-benzoyl peroxide 3.75% gel in moderate to severe acne vulgaris. (2016) (2)
Applications of Topical Oak Bark Extract in Dermatology: Clinical Examples and Discussion (2019) (2)
Prevalence and Demographics of Truncal Involvement Among Acne Patients: Survey Data and a Review of the Literature. (2022) (2)
Drug interactions of clinical significance to dermatologists: A primer and update (2000) (2)
Reply to "Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea". (2014) (2)
Cephalosporins in dermatology (2004) (2)
Solitary sclerotic fibroma. (2009) (2)
Ceramide- and Keratolytic-containing Body Cleanser and Cream Application in Patients with Psoriasis: Outcomes from a Consumer Usage Study. (2019) (2)
Topical retinoids in the management of acne: the best path to clear results. (2004) (2)
A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of acne vulgaris: aesthetic characteristics, patient preference considerations, and impact on compliance with treatment. (2009) (2)
The changing face of challenges in the management of acne and rosacea. (2014) (2)
Commentaries on ‘Minocycline for acne vulgaris: efficacy and safety’ with a response from the review authors (2011) (2)
Topical Corticosteroid Therapy for Psoriasis-A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification. (2020) (2)
The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review (2021) (2)
The Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles: Vehicle Characteristics Can Influence and Improve Patient Outcomes (2019) (2)
Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide/Clindamycin Combination Product: An Investigator-Blind, Randomized, Parallel-Group Study. (2008) (2)
Reply to "Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea". (2014) (2)
Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction. (2008) (2)
Topical management of acne vulgaris using a combination gel formulation: benzoyl peroxide 2.5%–clindamycin phosphate 1.2% gel (2010) (2)
Clindamycin phosphate-tretinoin combination gel revisited: status report on a specific formulation used for acne treatment. (2017) (2)
The use of foam vehicle topical corticosteroid formulations in combination with other topical agents: a clinical perspective based on available studies and observational use (2004) (1)
JAK inhibitors in the treatment of atopic dermatitis (2022) (1)
More from the Pipeline of Clinical Research on SELECTED SYSTEMIC THERAPIES FOR ATOPIC DERMATITIS. (2019) (1)
Efficacy and Safety of Microencapsulated Benzoyl Peroxide 3% and Microencapsulated Tretinoin 0.1% (E-Bpo/E-Atra) in Acne Vulgaris: Results from Two Randomized Controlled Clinical Trials (2021) (1)
The treatment of rosacea. (2004) (1)
A qualitative and quantitative assessment of the application and use of topical acne medication by patients. (2005) (1)
Updates & perspectives on management of common dermatologic disorders. (2007) (1)
What Is PFE? It May Just Be Time You Found Out.... (2019) (1)
Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream. (2014) (1)
The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream. (2013) (1)
Advancements in topical therapy (2022) (1)
Cutaneous rosacea: a thorough overview of pathogenesis, clinical presentations, and current recommendations on management (2016) (1)
LB784 Acne fulminans and its variants: Evidence-based expert panel recommendations (2016) (1)
More from the Pipeline of Clinical Research on SELECTED SYSTEMIC THERAPIES FOR ATOPIC DERMATITIS. (2019) (1)
Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report. (2021) (1)
Tapinarof Cream for the Treatment of Plaque Psoriasis: Efficacy and Safety by Baseline Disease Characteristics and Skin Type in a Phase 2b Randomized Study (2019) (1)
Furuncular Cutaneous Myiasis (1)
17800 Open-label extension study evaluating the long-term safety, efficacy, and tolerability of FMX103 1.5% topical minocycline foam in the treatment of moderate to severe facial papulopustular rosacea (2020) (1)
Status Report on Oral Isotretinoin in the Management of Acne Vulgaris: Why All the Discussion about Drug Absorption and Relapse Rates? (2013) (1)
Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies (2019) (1)
Adapalene 0.3%/benzoyl peroxide 2.5% gel plus oral doxycycline is an effective and safe option for oral isotretinion candidates with severe inflammatory acne (non-nodulocystic/non-conglobate) (2018) (1)
Polypodium Leucotomos Extract (PLE): New Study Gives Evidence-based Insight into "Ain't Nothing Like the Real Thing". (2019) (1)
Retinoid-Induced Flaring in Patients with Acne Vulgaris: Does It Really Exist?: A discussion of data from clinical studies with a gel formulation of clindamycin phosphate 1.2% and tretinoin 0.025%. (2008) (1)
Olumacostat Glasaretil (DRM01) for the Treatment of Acne Vulgaris: Primary Results from the DRM01-ACN02 Phase 2b Randomized Controlled Trial (2017) (1)
The use of topical imiquimod for cutaneous epithelial malignancies: clinical experience, optimal application regimens, patient follow-up and tolerability assessments (2004) (1)
An Update on the Latest Developments in Nonsteroidal Topical Therapy for Atopic Dermatitis. (2020) (1)
Rapid Improvement with BPX-01 Minocycline Topical Gel in the Treatment of Moderate-to-Severe Inflammatory Acne Vulgaris: a Randomized, Double-Blind, Vehicle-Controlled Study (2017) (1)
Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies (2020) (1)
SUPPLEMENT INDIVIDUAL ARTICLE: Optimizing Skin Care in Acne Treatment - Evaluation of a Designated Cleanser and Moisturizer Regimen With Improvement in Clinical Outcomes. (2022) (1)
Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study) (2023) (0)
Patient Satisfaction with Tapinarof Cream 1% Once Daily for Plaque Psoriasis in a Long-Term Extension Trial (2022) (0)
Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis (2023) (0)
Critical Evaluation of Benzoyl Peroxide in Rosacea: Old Challenges and New Clinical Opportunities With Encapsulated Benzoyl Peroxide (2022) (0)
Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis (2021) (0)
Hyperkeratotic papular eruptions on legs, arms, and back (2010) (0)
MONOCLONAL ANTIBODY THERAPIES for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management? (2019) (0)
Early Onset of Efficacy Using a 1% and 2% Topical Minocycline Gel for the Treatment of Rosacea: a Small Open Label Study (2018) (0)
Efficacy and Tolerability of Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis Involvement on the Face, Intertriginous, or Genital Areas: Pooled Results From Phase 3 Trials (DERMIS-1 and DERMIS-2) (2022) (0)
Incorporating the use of TNF inhibitors in the management of psoriasis from the perspective of the community dermatologist (2004) (0)
33463 Pooled efficacy and safety results from the DERMIS-1 and DERMIS-2 phase 3 trials of once-daily roflumilast cream 0.3% by baseline body surface area (2022) (0)
What Is PFE? It May Just Be Time You Found Out.... (2019) (0)
A New Frontier in Acne Treatment: Encapsulated Benzoyl Peroxide and Tretinoin (2022) (0)
Effect of Calcipotriene/Betamethasone Dipropionate 0.005%/0.064% Foam on Target Lesions in Plaque Psoriasis: A Post-Hoc Analysis (2020) (0)
将酒渣鼻表现型方法应用于实践和研究 (2018) (0)
Topical Azole Antimycotics for Superficial Fungal Infections (2007) (0)
Drug Actions , Reactions , and Interactions Cephalosporin Therapy in the Management of Uncomplicated Skin and Soft Tissue Infections (0)
Activity of Dapsone Versus Community and Hospital Bacterial Pathogens from the CANWARD Study (2017) (0)
Why are dermatologists still talking about acne? Because so many people have it... and we are always seeking better ways to manage it. (2011) (0)
Polypodium Leucotomos Extract (PLE): New Study Gives Evidence-based Insight into "Ain't Nothing Like the Real Thing". (2019) (0)
Once-Daily Halobetasol Propionate 0.01% Lotion for Moderate-to-Severe Plaque Psoriasis: Phase 3 Analysis of Hispanic Participants (2021) (0)
Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea (2022) (0)
JCADermatology Update on the Management of ACNE and ROSACEA from the American Acne and Rosacea Society ( AARS ) (2019) (0)
Del Rosso , DO , FAOCD Benzoyl Peroxide Microsphere Formulations : What is the Science Supporting Microsphere Vehicle Technology and Clinical Use ? (2009) (0)
Therapeutic experience with cefdinir in the treatment of uSSSIs. (2006) (0)
Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity (2022) (0)
Preface. Face to Face with Acne in 2016 and Beyond. (2016) (0)
Who Is Accountable When Patients Do Not Achieve Successful Treatment for Their Acne (2018) (0)
13882 Trifarotene 50 μg/g cream: An effective and safe treatment for moderate facial and truncal acne (2020) (0)
Once-Daily Halobetasol Propionate 0.01% Lotion for Moderate-to-Severe Plaque Psoriasis: Phase 3 Analysis of Hispanic Participants. (2021) (0)
A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris. (2022) (0)
Acne Vulgaris and Rosacea (2019) (0)
Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series (2022) (0)
Survey Study of Dermatologist and Patient Satisfaction with Halobetasol Propionate Lotion for the Treatment of Plaque Psoriasis (2017) (0)
Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients (2020) (0)
Contempo 1997: Dermatology (1997) (0)
Considerations in the Management of Actinic Keratoses: The Importance of Adherence and Persistence to Therapy (2021) (0)
Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety (0)
Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study) (2023) (0)
Long-term Safety and Efficacy of Fixed-Combination Halobetasol Propionate and Tazarotene Lotion in Patients With Clinically Meaningful Improvement in Plaque Psoriasis (2021) (0)
What's New in the Medicine Chest? Part 2 (2018) (0)
Treatment of seborrheic dermatitis: focus on the use of pimecrolimus (2004) (0)
LB756 Patient-reported outcomes for sarecycline effectiveness in Acne Vulgaris in real-world settings: PROSES study protocol (2021) (0)
Systemic Therapies for Acne Vulgaris and Rosacea (2007) (0)
An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period (2018) (0)
The Future of Contract Research Organizations in Dermatology and Aesthetic Research. (2022) (0)
The reemergence of sulfacetamide-sulfur formulations in the treatment of common inflammatory facial dermatoses: focus on the role of cleansers as adjunctive therapy in the treatment of rosacea (2004) (0)
An Expert Panel Questionnaire for Assessing Patient-Reported and Caregiver-Reported Outcomes in Acne Vulgaris (2022) (0)
Evaluating physician & patient perspectives regarding managment of seborrheic dermatitis: focus on antifungal shampoo therapy with ciclopirox (2004) (0)
Cutaneous rosacea: a thorough overview of pathogenesis, clinical presentations, and current recommendations on management (2016) (0)
27124 Impact of body mass index (BMI) on the efficacy and safety of halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion in patients with plaque psoriasis (2021) (0)
35165 Efficacy, tolerability, and cosmetic acceptability of an acne regimen specifically designed for sensitive skin (2022) (0)
Improvements in Acne and Skin Oiliness with Tazarotene 0.045% Lotion in Patients with Oily Skin. (2021) (0)
What's New in the Medicine Chest? Part 1 (2017) (0)
Applying the phenotype approach for rosacea to practice and research (2018) (0)
Contempo 1997: dermatology. (1997) (0)
Comprar Drug Actions, Reactions, and Interactions, An Issue of Dermatologic Clinics | J. Del Rosso | 9781416043058 | Saunders (2007) (0)
Adapting to Changes in Acne Management: Take One Step at a Time. (2022) (0)
Pipeline Perspectives and Therapy Updates. (2020) (0)
Clinically Important Considerations with the Use of Oral Doxycycline (2017) (0)
What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials. (2013) (0)
Just Like Rock and Roll, Topical Medications for Psoriasis Are Here to Stay. (2022) (0)
Capsule Commentaries: Selected Oral Antifungal Drug-Drug Interactions with Itraconazole and Terbinafine (2018) (0)
Pipeline Perspectives and Therapy Updates. (2020) (0)
13509 Integrated safety analysis of FMX103 1.5% topical minocycline foam for the treatment of moderate to severe papulopustular rosacea: Results from two phase 3 studies (2020) (0)
Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study Evaluating Efficacy and Safety (2021) (0)
What data support the use of minocycline in the treatment of acne vulgaris ? (2006) (0)
Investigator global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S in PROSES study: Analysis by concomitant medication (2023) (0)
Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS). (2020) (0)
Investigating Treatment of Primary Axillary Hyperhidrosis With a Topical Retrometabolic Anticholinergic Drug (2021) (0)
Anti-Inflammatory Dose Doxycycline (40 mg Delayed Release) Once Daily Versus Doxycycline 100 mg Once Daily for Rosacea (2009) (0)
Editorial message July highlights (2016) (0)
Management of Acne Vulgaris , Rosacea , and Perioral Dermatitis (2010) (0)
An Expert Panel Questionnaire for Assessing Patient-Reported and Clinician-Reported Outcomes in Actinic Keratosis (2022) (0)
Sarecycline Demonstrates Narrow spectrum Antibacterial Activity and Anti inflammatory Effect in Animal Models (2021) (0)
A current appraisal of drug interactions of significance in clinical practice: focus on antifungal therapeutic agents used in the treatment of superficial mycoses (2004) (0)
Disorders of Hair (2013) (0)
Efficacy and Saftey of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Doxycycline in Subjects with Severe Inflammatory Acne (Non-Nodulocystic) that are Candidates for Oral Isotretinoin (2017) (0)
25843 Tapinarof cream 1% once daily for plaque psoriasis: Patient-reported outcomes from two pivotal phase 3 trials (2021) (0)
Treatment of Darier's disease with isotretinoin: Report of a case (1986) (0)
Emerging therapies in pediatric atopic dermatitis patients (2022) (0)
The Scientific Panel on Antibiotic Usage in Dermatology ( SPAUD ) Part II : Continuation of A Summary Report On Usage Patterns , Management Challenges and Recommendations (0)
Clinical Manifestations and Management Considerations of Psoriasis Affecting The Nail Unit (2018) (0)
34970 Efficacy, tolerability, and consumer perception of a skincare regimen in patients with uneven skin tone (2022) (0)
The clinical value of benzoyl peroxide cleanser: formulation characteristics, method of use, drug deposition and clinical efficacy 1 ☆ (2004) (0)
Ceramide- and Keratolytic-containing Body Cleanser and Cream Application in Patients with Psoriasis: Outcomes from a Consumer Usage Study. (2019) (0)
Advances in Acne Management (2016) (0)
Why is it that the biggest resistance with fighting the battle against bacterial resistance seems to fall on dermatology clinicians? (2020) (0)
The use of oral tetracyclines for the treatment of common inflammatory facial dermatoses: perspectives on antibiotic vs anti-inflammatory dosing regimens (2004) (0)
Avoiding Prescribing Problems in Penicillin-Allergic Patients New information about cross-reactivity (0)
Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-world Settings: PROAK Study Protocol (2022) (0)
Why is it that the biggest resistance with fighting the battle against bacterial resistance seems to fall on dermatology clinicians (2020) (0)
AARS HOT TOPICS MEMBER NEWSLETTER (2022) (0)
Application of Nail Polish During Topical Management of Onychomycosis: Are Data Available to Guide the Clinician About What to Tell Their Patients? (2016) (0)
Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion. (2023) (0)
Painful Subcutaneous Nodules of the Lower Extremities (2010) (0)
Acne and rosacea. (2008) (0)
Efficacy and Safety of Tazarotene 0.045% Lotion in Caucasian Adults With Moderate-to-Severe Acne. (2022) (0)
The Personalised Acne Treatment Tool (PATT) – Recommendations to facilitate a patient-centered approach to acne management from the Personalising Acne: Consensus of Experts (PACE) (2023) (0)
Efficacy and Safety of Tazarotene 0.045% Lotion in White Adults with Moderate-to-Severe Acne (2021) (0)
Comprar Year Book of Dermatology and Dermatological Surgery 2010 | J. Del Rosso | 9780323068277 | Mosby (2010) (0)
What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials. (2013) (0)
Antibiotic Resistance Considerations of Importance to Clinical Dermatologists (2017) (0)
CONTEMPO 1997 : DERMATOLOGY. AUTHORS' REPLY (1997) (0)
Status Report on the Safety of Topical Dapsone Therapy for Dermatologic Disease (2018) (0)
专家组为医生提供治疗酒渣鼻的新建议 (2020) (0)
32846 Dual study: Trifarotene plus doxycycline has proven efficacy and safety in severe acne vulgaris (2022) (0)
Message from the guest editor. (2012) (0)
Understanding rosacea‐prone skin: Understanding the correlations between clinical manifestations and underlying pathophysiology (2021) (0)
Overstating Conclusions from Population-Based Data: Be Careful What You Wish For! (2016) (0)
Impact of acne on social functioning, emotional functioning, and activities of daily living among patients with moderate to severe non-nodular acne vulgaris administered sarecycline in real-world community practices across the U.S. (PROSES Study) (2022) (0)
Effective Treatment of Inflammatory Lesions of Rosacea with Subantibiotic Dose Doxycycline Irrespective of Patient Weight or Baseline Lesion Count Severity. (2022) (0)
Examining the available evidence of topical retinoid use in acne vulgaris: does initial exacerbation of acne commonly precede improvement and is it necessary to induce irritation in order to achieve clinical benefit? 1 (2004) (0)
Panel provides new recommendations and advice for doctors on rosacea (2020) (0)
The Future of Contract Research Organizations in Dermatology and Aesthetic Research. (2022) (0)
Who Is Accountable When Patients Do Not Achieve Successful Treatment for Their Acne? (2018) (0)
We are making progress with both acne and rosacea--but, let's face it! We still have a long way to go. (2010) (0)
Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Adult Age Groups. (2022) (0)
Acne symptoms and impact of acne on social functioning, emotional functioning, and activities of daily living (ADL) among pediatric patients with moderate to severe non-nodular Acne Vulgaris (AV) in community practices across the U.S: PROSES study (2023) (0)
Management of Acne & Rosacea: Working Toward the Same Goals…Facing New Challenges. (2015) (0)
Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Efficacy by Baseline Disease Characteristics and Demographics in Two Pivotal Phase 3 Trials (2021) (0)
An Update on the Latest Developments in Nonsteroidal Topical Therapy for Atopic Dermatitis. (2020) (0)
The new and old: Atopic dermatitis biologics (2022) (0)
The impact of atopic dermatitis on the quality of life (2022) (0)
Never Give Up! Continued Progress in Development of Topical Therapies for Acne Is a Good Thing. (2022) (0)
Antibiotic resistance: overview and significance in dermatology. (2005) (0)
Introduction to atopic dermatitis (2021) (0)
Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug (2022) (0)
Patient Reported Outcomes (PROs) and Investigator Global assessment (IGA) of Acne Vulgaris among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in real-world community practices across the U.S. (PROSES Study) (2022) (0)
Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections. (1998) (0)
LB938 Efficacy of FMX101 4% topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Integrated summary from three phase 3 studies (2020) (0)
Increased Uniformity in Diagnostic Accuracy of Pigmented Lesions Using Electrical Impedance Spectroscopy Information. (2021) (0)
Investigator global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: PROSES study analysis by gender and age (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With James Q. Del Rosso?

James Q. Del Rosso is affiliated with the following schools: